165 related articles for article (PubMed ID: 15321016)
1. Oral opportunistic infections in HIV-positive individuals: review and role of mucosal immunity.
Leigh JE; Shetty K; Fidel PL
AIDS Patient Care STDS; 2004 Aug; 18(8):443-56. PubMed ID: 15321016
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity, specificity, and positive predictive value of oral opportunistic infections in adults with HIV/AIDS as markers of immune suppression and viral burden.
Patton LL
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Aug; 90(2):182-8. PubMed ID: 10936837
[TBL] [Abstract][Full Text] [Related]
3. Lack of evidence for local immune activity in oral hairy leukoplakia and oral wart lesions.
Lilly EA; Cameron JE; Shetty KV; Leigh JE; Hager S; McNulty KM; Cheeks C; Hagensee ME; Fidel PL
Oral Microbiol Immunol; 2005 Jun; 20(3):154-62. PubMed ID: 15836516
[TBL] [Abstract][Full Text] [Related]
4. Oral manifestations in 70 German HIV-infected women.
Schmidt-Westhausen A; Grünewald T; Reichart PA; Pohle HD
Oral Dis; 1997 May; 3 Suppl 1():S28-30. PubMed ID: 9456652
[TBL] [Abstract][Full Text] [Related]
5. Immunity to Candida.
Fidel PL
Oral Dis; 2002; 8 Suppl 2():69-75. PubMed ID: 12164664
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of expression of HHV8, EBV and HPV in selected HIV-associated oral lesions.
Hille JJ; Webster-Cyriaque J; Palefski JM; Raab-Traub N
Oral Dis; 2002; 8 Suppl 2():161-8. PubMed ID: 12164651
[TBL] [Abstract][Full Text] [Related]
7. Correlation between oral lesions and opportunistic infections among human immunodeficiency virus - infected individuals in Indian population.
Sanadhya YK; Sanadhya S; Nagarajappa R; Jain S; Aapaliya P; Sharma N
Int Marit Health; 2014; 65(3):124-30. PubMed ID: 25471161
[TBL] [Abstract][Full Text] [Related]
8. Oral mucosal lesions in a UK HIV/AIDS oral medicine clinic. a nine year, cross-sectional, prospective study.
Zakrzewska JM; Atkin PA
Oral Health Prev Dent; 2003; 1(1):73-9. PubMed ID: 15643751
[TBL] [Abstract][Full Text] [Related]
9. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS?
Ceballos-Salobreña A; Gaitán-Cepeda LA; Ceballos-Garcia L; Lezama-Del Valle D
AIDS Patient Care STDS; 2000 Dec; 14(12):627-35. PubMed ID: 11119429
[TBL] [Abstract][Full Text] [Related]
10. Immunologic status in patients infected with HIV with oral candidiasis and hairy leukoplakia.
Kolokotronis A; Kioses V; Antoniades D; Mandraveli K; Doutsos I; Papanayotou P
Oral Surg Oral Med Oral Pathol; 1994 Jul; 78(1):41-6. PubMed ID: 8078662
[TBL] [Abstract][Full Text] [Related]
11. Changing prevalence of human immunodeficiency virus-associated oral lesions.
Dios PD; Ocampo A; Miralles C; Limeres J; Tomás I
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Oct; 90(4):403-4. PubMed ID: 11027372
[No Abstract] [Full Text] [Related]
12. Sentinels and signposts: the epidemiology and significance of the oral manifestations of HIV disease.
Greenspan JS
Oral Dis; 1997 May; 3 Suppl 1():S13-7. PubMed ID: 9456650
[TBL] [Abstract][Full Text] [Related]
13. Oral mucosal lesions and HIV viral load in the Women's Interagency HIV Study (WIHS).
Greenspan D; Komaroff E; Redford M; Phelan JA; Navazesh M; Alves ME; Kamrath H; Mulligan R; Barr CE; Greenspan JS
J Acquir Immune Defic Syndr; 2000 Sep; 25(1):44-50. PubMed ID: 11064503
[TBL] [Abstract][Full Text] [Related]
14. Oral mucosal lesions and immune status in HIV-infected Indian children.
Subramaniam P; Kumar K
J Oral Pathol Med; 2015 Apr; 44(4):296-9. PubMed ID: 25212254
[TBL] [Abstract][Full Text] [Related]
15. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
Ortega KL; Vale DA; Magalhães MH
J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
[TBL] [Abstract][Full Text] [Related]
16. Oral manifestations related to immunosuppression degree in HIV-positive children.
Santos LC; Castro GF; de Souza IP; Oliveira RH
Braz Dent J; 2001; 12(2):135-8. PubMed ID: 11450684
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of HIV-related oral manifestations and their association with HAART and CD4+ T cell count: a review.
Ottria L; Lauritano D; Oberti L; Candotto V; Cura F; Tagliabue A; Tettamanti L
J Biol Regul Homeost Agents; 2018; 32(2 Suppl. 1):51-59. PubMed ID: 29460518
[TBL] [Abstract][Full Text] [Related]
18. Association between oral candidiasis and low CD4+ count among HIV positive patients in Hoima Regional Referral Hospital.
Nanteza M; Tusiime JB; Kalyango J; Kasangaki A
BMC Oral Health; 2014 Nov; 14():143. PubMed ID: 25432363
[TBL] [Abstract][Full Text] [Related]
19. Risk indicators for oral candidiasis and oral hairy leukoplakia in HIV-infected adults.
Chattopadhyay A; Caplan DJ; Slade GD; Shugars DC; Tien HC; Patton LL
Community Dent Oral Epidemiol; 2005 Feb; 33(1):35-44. PubMed ID: 15642045
[TBL] [Abstract][Full Text] [Related]
20. Effect of highly active antiretroviral therapy on frequency of oral warts.
Greenspan D; Canchola AJ; MacPhail LA; Cheikh B; Greenspan JS
Lancet; 2001 May; 357(9266):1411-2. PubMed ID: 11356441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
